These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8757110)

  • 1. [Cost-benefit analysis of the therapy of lipid metabolism disorders].
    Karádi I
    Orv Hetil; 1996 May; 137(21):1164. PubMed ID: 8757110
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statines for all or individualized lipid lowering therapy?].
    Parhofer K
    MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of hyperlipidemia in diabetes.
    Vinik AI; O'Brian JT; Georges LP; Leichter SB; Janin Y
    Compr Ther; 1995 Oct; 21(10):602-9. PubMed ID: 8565431
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of disorders of lipid metabolism--gastroenterologic aspects].
    Steinmetz A
    Z Arztl Fortbild (Jena); 1992 May; 86(9):437-44. PubMed ID: 1318619
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lipid metabolism disorders: diagnosis and treatment. 4: Drug therapy and dietary recommendations. National Cholesterin-Initiative].
    Fortschr Med; 1991 May; 109(16):344-7. PubMed ID: 1855762
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing hyperlipidaemia.
    Nestel PJ
    Med J Aust; 1988 Jan; 148(1):29-31. PubMed ID: 3336296
    [No Abstract]   [Full Text] [Related]  

  • 7. [Also elderly patients with hyperlipidemia and coronary disease need lipid lowering agents].
    Hellénius ML
    Lakartidningen; 2001 Sep; 98(39):4188-90. PubMed ID: 11680152
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
    Broncel M; Balcerak M; Chojnowska-Jezierska J
    Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical management for hyperlipidemia.
    Robinson JG; Hunninghake DB
    Contemp Intern Med; 1995 Feb; 7(2):15-6, 19-27. PubMed ID: 10150335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Practice guidelines--disorders of lipid metabolism. From recommendations to therapy of disorders of lipid metabolism by the Drug Committee of the German Medical Society. Drug Committee of the German Medical Society].
    Z Arztl Fortbild Qualitatssich; 2000 Jan; 94(1):61-4. PubMed ID: 10721166
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid lowering strategies.
    Morrell J
    Indian Heart J; 1999; 51(5):489-93. PubMed ID: 10721637
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of hyperlipidemia].
    Müller G
    Dtsch Gesundheitsw; 1971 Oct; 26(43):2020-4. PubMed ID: 4947270
    [No Abstract]   [Full Text] [Related]  

  • 13. NHF guidelines on the management of dyslipidaemia.
    Mann J; Agnew T
    N Z Med J; 1996 Sep; 109(1029):345. PubMed ID: 8862356
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of hypolipemic drugs on the level of serum lipids in workers and clerks].
    Zulić I; Stanković D; Mulabegovic N; Valjevac K; Serdarević D
    Med Arh; 1978; 32(1):3-6. PubMed ID: 713612
    [No Abstract]   [Full Text] [Related]  

  • 15. [44. Normalizing blood lipids--with diet, sports and antilipemic agents].
    Faust M; Krone W
    MMW Fortschr Med; 2003 May; 145(19):I-X; quiz XI-XII. PubMed ID: 12813992
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of lipid metabolism disorders in the elderly].
    Mizera W; Grzeszczak W
    Wiad Lek; 1998; 51 Suppl 2():52-7. PubMed ID: 9686534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of glucagon on plasma lipids in normal and hyperlipemic subjects].
    Jover E; Berdugo A; Rodríguez F; Velasco R
    Rev Clin Esp; 1985 Apr; 176(6):281-5. PubMed ID: 4001485
    [No Abstract]   [Full Text] [Related]  

  • 18. The human and economic costs of undertreatment with statins.
    Durrington P
    Int J Clin Pract; 2002 Jun; 56(5):357-68. PubMed ID: 12137445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of dyslipidemia.
    Akel MM; Salti I
    J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum lipid disorders: what levels should you aim for?
    Rees ED
    Geriatrics; 1981 Feb; 36(2):77-86. PubMed ID: 7450512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.